Dietary Turmeric Bisdemethoxycurcumin Suppresses Wilms’ Tumor 1 and CD34 Protein Expressions in KG-1a Leukemic Stem Cells

References

• Geethanjali A, Lalitha P, and Jannathul Firdhouse M: Analysis of curcumin content of turmeric samples from various states of India. Int J Pharma Chem Res 2, 55–62, 2016.
   Google Scholar
• Feller N, van der Pol MA, van Stijn A, Weijers GWD, Westra AH, et al. MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia. Leukemia 18, 1380–1390, 2004.
   PubMed Web of Science ®Google Scholar
• van Rhenen A, Feller N, Kelder A, Westra AH, Rombouts E, et al. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clin Cancer Res 11, 6520–6527, 2005. doi: 10.1158/1078-0432.ccr-05-0468
   PubMed Web of Science ®Google Scholar
• Lutz C, Woll PS, Hall G, Castor A, Dreau H, et al. Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia. Leukemia 27, 1204–1207, 2013. doi: 10.1038/leu.2012.306
   PubMed Web of Science ®Google Scholar
• Bonnet D, and Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3, 730–737, 1997.
   PubMed Web of Science ®Google Scholar
• Graham SM, Jørgensen HG, Allan E, Pearson C, Alcorn MJ, et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99, 319–325, 2002.
   PubMed Web of Science ®Google Scholar
• Jordan CT, Guzman ML, and Noble M: Cancer stem cells. N Engl J Med 355, 1253–1261, 2006. doi: 10.1056/NEJMra061808
   PubMed Web of Science ®Google Scholar
• Abdullah LN, and Chow E-H: Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med 2, 3, 2013. doi: 10.1186/2001-1326-2-3
   PubMedGoogle Scholar
• Fraizer G, Patmasiriwat P, Zhang X, and Saunders G: Expression of the tumor suppressor gene WT1 in both human and mouse bone marrow [letter]. Blood 86, 4704–4706, 1995.
   PubMed Web of Science ®Google Scholar
• Baird PN, and Simmons PJ: Expression of the Wilms’ tumor gene (WT1) in normal hemopoiesis. Exp Hematol 25, 312–320, 1997.
   PubMed Web of Science ®Google Scholar
• Hosen N, Sonoda Y, Oji Y, Kimura T, Minamiguchi H, et al. Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms’ tumour gene WT1 at levels similar to those in leukaemia cells. Br J Haematol 116, 409–420, 2002.
   PubMed Web of Science ®Google Scholar
• Coppes MJ, Campbell CE, and Williams BR: The role of WT1 in Wilms tumorigenesis. FASEB J 7, 886–895, 1993.
   PubMed Web of Science ®Google Scholar
• Yamagami T, Sugiyama H, Inoue K, Ogawa H, Tatekawa T, et al. Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood 87, 2878–2884, 1996.
   PubMed Web of Science ®Google Scholar
• Brown EJ, and Frazier WA: Integrin-associated protein (CD47) and its ligands. Trends Cell Biol 11, 130–135, 2001. doi: 10.1016/S0962-8924(00)01906-1
   PubMed Web of Science ®Google Scholar
• Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84, 3071–3079, 1994.
   PubMed Web of Science ®Google Scholar
• Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, et al. High levels of Wilms’ tumor gene (WT1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 90, 1217–1225, 1997.
   PubMed Web of Science ®Google Scholar
• Barragan E, Cervera J, Bolufer P, Ballester S, Martin G, et al. Prognostic implications of Wilms’ tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Haematologica 89, 926–933, 2004.
   PubMed Web of Science ®Google Scholar
• Tamaki H, Ogawa H, Inoue K, Soma T, Yamagami T, et al. Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia [letter]. Blood 88, 4396–4398, 1996.
   PubMed Web of Science ®Google Scholar
• Ammon HP, and Wahl MA: Pharmacology of curcuma longa. Planta Med 57, 1–7, 1991. doi: 10.1055/s-2006-960004
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Sundaram C, Malani N, and Ichikawa H: Curcumin: the indian solid gold. Adv Exp Med Biol 595, 1–75, 2007. doi: 10.1007/978-0-387-46401-5_1
   PubMed Web of Science ®Google Scholar
• Amalraj A, Pius A, Gopi S, and Gopi S: Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives – A review. J Tradit Complement Med 7, 205–233, 2017. doi: 10.1016/j.jtcme.2016.05.005
   PubMedGoogle Scholar
• Anuchapreeda S, Thanarattanakorn P, Sittipreechacharn S, Chanarat P, and Limtrakul P: Curcumin inhibits WT1 gene expression in human leukemic K562 cells. Acta Pharmacol Sin 27, 360–366, 2006. doi: 10.1111/j.1745-7254.2006.00291.x
   PubMed Web of Science ®Google Scholar
• Anuchapreeda S, Limtrakul P, Thanarattanakorn P, Sittipreechacharn S, and Chanarat P: Inhibitory effect of curcumin on WT1 gene expression in patient leukemic cells. Arch Pharm Res 29, 80–87, 2006.
   PubMed Web of Science ®Google Scholar
• Anuchapreeda S, Tima S, Duangrat C, and Limtrakul P: Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines. Cancer Chemother Pharmacol 62, 585–594, 2008. doi: 10.1007/s00280-007-0642-1
   PubMed Web of Science ®Google Scholar
• Semsri S, Krig SR, Kotelawala L, Sweeney CA, and Anuchapreeda S: Inhibitory mechanism of pure curcumin on Wilms’ tumor 1 (WT1) gene expression through the PKCα signaling pathway in leukemic K562 cells. FEBS Lett 585, 2235–2242, 2011. doi: 10.1016/j.febslet.2011.05.043
   PubMed Web of Science ®Google Scholar
• Limtrakul P, Anuchapreeda S, and Buddhasukh D: Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 4, 13, 2004. doi: 10.1186/1471-2407-4-13
   PubMed Web of Science ®Google Scholar
• Chearwae W, Anuchapreeda S, Nandigama K, Ambudkar SV, and Limtrakul P: Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder. Biochem Pharmacol 68, 2043–2052, 2004. doi: 10.1016/j.bcp.2004.07.009
   PubMed Web of Science ®Google Scholar
• Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645–648, 1994.
   PubMed Web of Science ®Google Scholar
• Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, et al. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87, 1539–1548, 1996.
   PubMed Web of Science ®Google Scholar
• de Figueiredo-Pontes LL, Pintao MC, Oliveira LC, Dalmazzo LF, Jacomo RH, et al. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia. Cytometry Part Cytometry 74, 163–168, 2008. doi: 10.1002/cyto.b.20403
   PubMed Web of Science ®Google Scholar
• Tima S, Ichikawa H, Ampasavate C, Okonogi S, and Anuchapreeda S: Inhibitory effect of turmeric curcuminoids on FLT3 expression and cell cycle arrest in the FLT3-overexpressing EoL-1 leukemic cell line. J Nat Prod 77, 948–954, 2014. doi: 10.1021/np401028h
   PubMed Web of Science ®Google Scholar
• Furley AJ, Reeves BR, Mizutani S, Altass LJ, Watt SM, et al. Divergent molecular phenotypes of KG1 and KG1a myeloid cell lines. Blood 68, 1101–1107, 1986.
   PubMed Web of Science ®Google Scholar
• Fuchs D, Daniel V, Sadeghi M, Opelz G, and Naujokat C: Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun 394, 1098–1104, 2010. doi: 10.1016/j.bbrc.2010.03.138
   PubMed Web of Science ®Google Scholar
• She M, Niu X, Chen X, Li J, Zhou M, et al. Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity. Cancer Lett 318, 173–179, 2012. doi: 10.1016/j.canlet.2011.12.017
   PubMed Web of Science ®Google Scholar
• Panyajai P, Amnajphook N, Keawsangthongcharoen S, Chiampanichayakul S, Tima S, et al. Study of leukemic stem cell population (CD34+/CD38-) and WT1 protein expression in human leukemic cell lines. J Associated Med Sci 51, 38–44, 2018.
   Google Scholar
• Hosen N, Shirakata T, Nishida S, Yanagihara M, Tsuboi A, et al. The Wilms’ tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis. Leukemia 21, 1783–1791, 2007. doi: 10.1038/sj.leu.2404752
   PubMed Web of Science ®Google Scholar
• Saito Y, Kitamura H, Hijikata A, Tomizawa-Murasawa M, Tanaka S, et al. Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci Transl Med 2, 17ra9, 2010. doi: 10.1126/scitranslmed.3000349
   PubMed Web of Science ®Google Scholar
• Madden SL, Cook DM, and Rauscher FJ: 3rd: A structure-function analysis of transcriptional repression mediated by the WT1, Wilms’ tumor suppressor protein. Oncogene 8, 1713–1720, 1993.
   PubMed Web of Science ®Google Scholar
• Liu JY, Lin SJ, and Lin JK: Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis 14, 857–861, 1993.
   PubMed Web of Science ®Google Scholar
• Reddy S, and Aggarwal BB: Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett 341, 19–22, 1994.
   PubMed Web of Science ®Google Scholar
• Weng G, Zeng Y, Huang J, Fan J, and Guo K: Curcumin enhanced busulfan-induced apoptosis through downregulating the expression of survivin in leukemia stem-like KG1a cells. BioMed Res Int 2015, 630397, 2015. doi: 10.1155/2015/630397
   PubMed Web of Science ®Google Scholar
• Jayaprakasha GK, Jaganmohan Rao L, and Sakariah KK: Antioxidant activities of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Chem 98, 720–724, 2006. doi: 10.1016/j.foodchem.2005.06.037
   Web of Science ®Google Scholar
• Ak T, and Gülçin İ: Antioxidant and radical scavenging properties of curcumin. Chemico-Biol Interact 174, 27–37, 2008. doi: 10.1016/j.cbi.2008.05.003
   PubMed Web of Science ®Google Scholar
• Galano A, Álvarez-Diduk R, Ramírez-Silva MT, Alarcón-Ángeles G, and Rojas-Hernández A: Role of the reacting free radicals on the antioxidant mechanism of curcumin. Chem Phys 363, 13–23, 2009. doi: 10.1016/j.chemphys.2009.07.003
   Web of Science ®Google Scholar
• Fischer N, Seo E-J, and Efferth T: Prevention from radiation damage by natural products. Phytomedicine 47, 192–200, 2018. doi: 10.1016/j.phymed.2017.11.005
   PubMed Web of Science ®Google Scholar
• Panahi Y, Hosseini MS, Khalili N, Naimi E, Majeed M, et al. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. Clin Nutr 34, 1101–1108, 2015. doi: 10.1016/j.clnu.2014.12.019
   PubMed Web of Science ®Google Scholar
• Cooney JM, Barnett MPG, Dommels YEM, Brewster D, Butts CA, et al. A combined omics approach to evaluate the effects of dietary curcumin on colon inflammation in the Mdr1a−/− mouse model of inflammatory bowel disease. J Nutr Biochem 27, 181–192, 2016. doi: 10.1016/j.jnutbio.2015.08.030
   PubMed Web of Science ®Google Scholar
• Yang H, Du Z, Wang W, Song M, Sanidad K, et al. Structure–activity relationship of curcumin: role of the methoxy group in anti-inflammatory and anticolitis effects of curcumin. J Agric Food Chem 65, 4509–4515, 2017. doi: 10.1021/acs.jafc.7b01792
   PubMed Web of Science ®Google Scholar
• Negi PS, Jayaprakasha GK, Jagan Mohan Rao L, and Sakariah KK: Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J Agric Food Chem 47, 4297–4300, 1999.
   PubMed Web of Science ®Google Scholar
• Anuchapreeda S, Leechanachai P, Smith M, Ambudkar SV, and Limtrakul P: Modulation of P-glycoprotein expression and function by curcumin in Multidrug resistant human KB cells. Biochem Pharmacol 64, 573–582, 2002. doi: 10.1016/s0006-2952(02)01224-8
   PubMed Web of Science ®Google Scholar
• Radhakrishna Pillai G, Srivastava AS, Hassanein TI, Chauhan DP, and Carrier E: Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett 208, 163–170, 2004. doi: 10.1016/j.canlet.2004.01.008
   PubMed Web of Science ®Google Scholar
• Yodkeeree S, Chaiwangyen W, Garbisa S, and Limtrakul P: Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. J Nutr Biochem 20, 87–95, 2009. doi: 10.1016/j.jnutbio.2007.12.003
   PubMed Web of Science ®Google Scholar
• Liu X, Sun K, Song A, Zhang X, Zhang X, et al. Curcumin inhibits proliferation of gastric cancer cells by impairing ATP-sensitive potassium channel opening. World J Surg Onc 12, 389, 2014. doi: 10.1186/1477-7819-12-389
   PubMed Web of Science ®Google Scholar
• Tima S, Okonogi S, Ampasavate C, Pickens C, Berkland C, et al. Development and characterization of FLT3-specific curcumin-loaded polymeric micelles as a drug delivery system for treating FLT3-overexpressing leukemic cells. J Pharm Sci 105, 3645–3657, 2016. doi: 10.1016/j.xphs.2016.09.010
   PubMed Web of Science ®Google Scholar
• Li H, Krstin S, and Wink M: Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin. Phytomedicine 50, 213–222, 2018. doi: 10.1016/j.phymed.2018.09.169
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Fried A, Hussaini R, White R, Baidoo J, et al. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells. J Exp Clin Cancer Res 37, 168, 2018. doi: 10.1186/s13046-018-0792-5
   PubMed Web of Science ®Google Scholar
• Tima S, Okonogi S, Ampasavate C, Berkland C, and Anuchapreeda S: FLT3-specific curcumin micelles enhance activity of curcumin on FLT3-ITD overexpressing MV4-11 leukemic cells. Drug Dev Ind Pharm 45, 498–505, 2019. doi: 10.1080/03639045.2018.1562462
   Web of Science ®Google Scholar
• Kamalabadi-Farahani M, Vasei M, Ahmadbeigi N, Ebrahimi-Barough S, Soleimani M, et al. Anti-tumour effects of TRAIL-expressing human placental derived mesenchymal stem cells with curcumin-loaded chitosan nanoparticles in a mice model of triple negative breast cancer. Artif Cells, Nanomed Biotechnol 1–11, 2018. doi: 10.1080/21691401.2018.1527345
   Web of Science ®Google Scholar
• Kumar G, Farooqui M, and Rao CV: Role of dietary cancer-preventive phytochemicals in pancreatic cancer stem cells. Curr Pharmacol Rep 4, 326–335, 2018. doi: 10.1007/s40495-018-0145-2
   PubMedGoogle Scholar
• Wang J, Wang C, and Bu G: Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. Exp Ther Med 15, 3650–3658, 2018. doi: 10.3892/etm.2018.5805
   PubMed Web of Science ®Google Scholar
• Li Y, Domina A, Lim G, Chang T, and Zhang T: Evaluation of curcumin, a natural product in turmeric, on Burkitt lymphoma and acute myeloid leukemia cancer stem cell markers. Future Oncol 14, 2353–2360, 2018. doi: 10.2217/fon-2018-0202
   PubMed Web of Science ®Google Scholar
• Bao B, Ali S, Banerjee S, Wang Z, Logna F, et al. Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res 72, 335–345, 2012. doi: 10.1158/0008-5472.CAN-11-2182
   PubMed Web of Science ®Google Scholar
• Zendehdel E, Abdollahi E, Momtazi-Borojeni AA, Korani M, Alavizadeh SH, et al. The molecular mechanisms of curcumin’s inhibitory effects on cancer stem cells. J Cell Biochem 120, 4739–4747, 2019. doi: 10.1002/jcb.27757
   Web of Science ®Google Scholar
• Sheefa M, Aakanksha V, Hemangini V, Nayan J, and Rakesh R: Curcumin targets circulating cancer stem cells by inhibiting self-renewal efficacy in non-small cell lung carcinoma. Anti-Cancer Agents Med Chem 17, 859–864, 2017. doi: 10.2174/1871520616666160923102549
   PubMed Web of Science ®Google Scholar
• Zakaria N, Satar NA, Abu Halim NH, Ngalim SH, Yusoff NM, et al. Targeting lung cancer stem cells: research and clinical impacts. Front Oncol 7, 80, 2017. doi: 10.3389/fonc.2017.00080
   PubMed Web of Science ®Google Scholar
• Bao B, Ali S, Ahmad A, Azmi AS, Li Y, et al. Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. PloS One 7, e50165, 2012. doi: 10.1371/journal.pone.0050165
   PubMed Web of Science ®Google Scholar
• Sun CY, Liu XY, Chen Y, Liu F, and Wang Y: Experimental study on anticancer effect of curcumin on Raji cells in vitro. Zhongguo Zhong xi yi Jie he za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine 24, 1003–1006, 2004.
   PubMedGoogle Scholar
• Yue GGL, Chan BCL, Hon P-M, Lee MYH, Fung K-P, et al. Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa. Food Chem Toxicol 48, 2011–2020, 2010. doi: 10.1016/j.fct.2010.04.039
   PubMed Web of Science ®Google Scholar
• Gopal PK, Paul M, and Paul S: Curcumin induces caspase mediated apoptosis in JURKAT cells by disrupting the redox balance. Asian Pac J Cancer Prev 15, 93–100, 2014.
   PubMedGoogle Scholar
• Fackler MJ, Civin CI, Sutherland DR, Baker MA, and May WS: Activated protein kinase C directly phosphorylates the CD34 antigen on hematopoietic cells. J Biol Chem 265, 11056–11061, 1990.
   PubMed Web of Science ®Google Scholar
• Fackler MJ, Civin CI, and May WS: Up-regulation of surface CD34 is associated with protein kinase C-mediated hyperphosphorylation of CD34. J Biol Chem 267, 17540–17546, 1992.
   PubMed Web of Science ®Google Scholar
• Krause DS, Ito T, Fackler MJ, Smith OM, Collector MI, et al. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 84, 691–701, 1994.
   PubMed Web of Science ®Google Scholar
• Nielsen JS, and McNagny KM: Novel functions of the CD34 family. J Cell Sci 121, 3683–3692, 2008. doi: 10.1242/jcs.037507
   PubMed Web of Science ®Google Scholar